MX2019002248A - Proteina de union al factor h modificada. - Google Patents
Proteina de union al factor h modificada.Info
- Publication number
- MX2019002248A MX2019002248A MX2019002248A MX2019002248A MX2019002248A MX 2019002248 A MX2019002248 A MX 2019002248A MX 2019002248 A MX2019002248 A MX 2019002248A MX 2019002248 A MX2019002248 A MX 2019002248A MX 2019002248 A MX2019002248 A MX 2019002248A
- Authority
- MX
- Mexico
- Prior art keywords
- modified
- binding protein
- factor binding
- fhbp
- modified factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1614687.0A GB201614687D0 (en) | 2016-08-31 | 2016-08-31 | fHbp scaffold |
| PCT/GB2017/052535 WO2018042178A1 (en) | 2016-08-31 | 2017-08-31 | Modified factor h binding protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019002248A true MX2019002248A (es) | 2019-09-18 |
Family
ID=57119942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019002248A MX2019002248A (es) | 2016-08-31 | 2017-08-31 | Proteina de union al factor h modificada. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3506934A1 (enExample) |
| JP (1) | JP7525093B2 (enExample) |
| KR (1) | KR102643280B1 (enExample) |
| CN (1) | CN109890412B (enExample) |
| AU (1) | AU2017319218B2 (enExample) |
| BR (1) | BR112019003957A2 (enExample) |
| CA (1) | CA3035159A1 (enExample) |
| GB (2) | GB201614687D0 (enExample) |
| IL (1) | IL265078B2 (enExample) |
| MX (1) | MX2019002248A (enExample) |
| WO (1) | WO2018042178A1 (enExample) |
| ZA (1) | ZA201901862B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110903400A (zh) * | 2019-11-08 | 2020-03-24 | 苏州微超生物科技有限公司 | B群脑膜炎球菌fHBP多变体融合蛋白及其制备方法与应用 |
| CN111533792B (zh) | 2020-07-07 | 2020-10-16 | 康希诺生物股份公司 | 一种定点突变的载体蛋白及其在制备疫苗中的用途 |
| CN116323680A (zh) * | 2020-09-29 | 2023-06-23 | 出光兴产株式会社 | 肽标签和包含其的附加有标签的蛋白 |
| IN202321021121A (enExample) * | 2023-03-24 | 2024-04-19 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0419408D0 (en) * | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| ES2557282T3 (es) * | 2008-03-10 | 2016-01-25 | Children's Hospital & Research Center At Oakland | Proteínas quiméricas de unión al factor H (fHBP) que contienen un dominio B heterólogo, y métodos de uso |
| BR112012004275A2 (pt) * | 2009-08-27 | 2016-11-16 | Novartis Ag | polipeptídios híbridos incluindo sequências meningocócicas de fhbp |
| GB201015132D0 (en) * | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| AU2015352404A1 (en) * | 2014-11-28 | 2017-05-18 | Janssen Vaccines & Prevention B.V. | Meningitis B vaccine |
-
2016
- 2016-08-31 GB GBGB1614687.0A patent/GB201614687D0/en not_active Ceased
-
2017
- 2017-08-31 KR KR1020197008694A patent/KR102643280B1/ko active Active
- 2017-08-31 GB GB1903866.0A patent/GB2568440B/en active Active
- 2017-08-31 MX MX2019002248A patent/MX2019002248A/es unknown
- 2017-08-31 CA CA3035159A patent/CA3035159A1/en active Pending
- 2017-08-31 JP JP2019511993A patent/JP7525093B2/ja active Active
- 2017-08-31 WO PCT/GB2017/052535 patent/WO2018042178A1/en not_active Ceased
- 2017-08-31 BR BR112019003957A patent/BR112019003957A2/pt unknown
- 2017-08-31 AU AU2017319218A patent/AU2017319218B2/en active Active
- 2017-08-31 EP EP17762178.6A patent/EP3506934A1/en active Pending
- 2017-08-31 CN CN201780060701.6A patent/CN109890412B/zh active Active
-
2019
- 2019-02-27 IL IL265078A patent/IL265078B2/en unknown
- 2019-03-26 ZA ZA2019/01862A patent/ZA201901862B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL265078A (enExample) | 2019-04-30 |
| IL265078B1 (en) | 2023-04-01 |
| GB2568440B (en) | 2022-08-17 |
| NZ751995A (en) | 2024-03-22 |
| BR112019003957A2 (pt) | 2019-06-25 |
| CN109890412A (zh) | 2019-06-14 |
| ZA201901862B (en) | 2020-09-30 |
| WO2018042178A1 (en) | 2018-03-08 |
| CN109890412B (zh) | 2025-04-04 |
| AU2017319218A1 (en) | 2019-04-18 |
| CA3035159A1 (en) | 2018-03-08 |
| GB201903866D0 (en) | 2019-05-08 |
| IL265078B2 (en) | 2023-08-01 |
| US20220112249A1 (en) | 2022-04-14 |
| EP3506934A1 (en) | 2019-07-10 |
| JP7525093B2 (ja) | 2024-07-30 |
| AU2017319218A2 (en) | 2019-05-02 |
| GB201614687D0 (en) | 2016-10-12 |
| AU2017319218B2 (en) | 2021-10-28 |
| KR102643280B1 (ko) | 2024-03-05 |
| GB2568440A (en) | 2019-05-15 |
| KR20190064577A (ko) | 2019-06-10 |
| JP2019526261A (ja) | 2019-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022000448A1 (es) | Autoinyector (divisional solicitud no. 201903061) | |
| EA202190983A1 (ru) | Новое антитело к с-kit | |
| PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
| EA201990071A1 (ru) | Композиция пептидной вакцины | |
| BR112017018276A2 (pt) | ?composição que compreende peptidase e biotensoativo e seu uso? | |
| EA201991798A1 (ru) | Стабильные при хранении составы | |
| SA521421715B1 (ar) | تركيبات سيماجلوتيد ثابتة واستخداماتها | |
| PE20170955A1 (es) | Nuevas proteinas inhibidoras de insectos | |
| EA202191175A1 (ru) | Сконструированные с цистеином конъюгаты антитело-лекарственное средство, содержащие пептидсодержащие линкеры | |
| MX2019002248A (es) | Proteina de union al factor h modificada. | |
| MX389026B (es) | Una composicion farmaceutica y el uso de la misma. | |
| MX2017003117A (es) | Particula tipo virus de flavivirus. | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| BR112021020883A2 (pt) | Formas sólidas de um inibidor de glyt1 | |
| PH12020551618A1 (en) | Erenumab compositions and uses thereof | |
| AR106981A1 (es) | Una composición antimicrobiana | |
| MX2021015961A (es) | Moleculas novedosas. | |
| EA202191403A1 (ru) | Композиция с высокой концентрацией белка | |
| MX2017013879A (es) | Composiciones que comprenden anakinra. | |
| EA202090971A1 (ru) | Способы применения и композиции, содержащие дулаглутид | |
| CL2020002347A1 (es) | Nuevo compuesto y composición farmacéutica que lo comprende | |
| MX2021013833A (es) | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). | |
| EA201890209A1 (ru) | Композиция, содержащая танины | |
| MX2017003949A (es) | Derivados peptidicos novedosos y sus usos. | |
| MX2021001361A (es) | Composicion liquida de fibrinogeno humano. |